As of February 27, 2020, the FDA continues to alert healthcare professionals and patients about the recall of Zantac, a generic named Ranitidine. If you or a loved one have recently taken Zantac, this announcement may be cause for concern. In particular, you may wonder if it is safe to continue taking Zantac or whether previous doses could endanger you.
What Has the FDA Released So Far?
In September 2019, FDA testing revealed that Zantac contained low levels of a chemical known as N-nitrosodimethylamine (NDMA). NDMA is considered an environmental contaminant potentially found in soil, air, or water and may be present in certain foods or medicines. NDMA is considered a probable carcinogen and may cause cancer.
The FDA released that above a certain threshold, the NDMA found in drugs containing Ranitidine, including Zantac, has the potential to cause cancer in humans. Therefore, the FDA has instructed companies to recall Ranitidine drugs if NDMA exceeds 96 mg in the recommended daily dosage. Multiple companies, including Zantac’s parent company Sanofi, have recalled Ranitidine products.
What Are the Potential Problems?
Zantac and other Ranitidine-containing drugs aim to prevent issues like GERD and chronic heartburn. While some are over-the-counter, stronger formulations require prescriptions for severe cases. The drug functions as an H2 blocker, curbing excessive stomach acid release. However, studies reveal a potential link between elevated NDMA levels and colorectal and other cancers. While the FDA has ordered individual testing, independent research suggests Zantac may significantly surpass FDA limits, potentially causing cancer.
What Should You Do?
The FDA does not currently instruct patients to stop taking Zantac. However, as other H2 inhibitors haven’t been found to include NDMA, the FDA advises patients to consult a physician about switching. The FDA will provide regular updates regarding its test results. If you or a loved one developed cancer after taking Zantac, speak with an attorney about potential legal action. You may be eligible for compensation due to your injuries.
The attorneys at Gallon, Takacs & Boissoneault Co., L.P.A are accomplished in harmful drug cases and can assist you in pursuing any necessary legal action – call us at (419) 843-6663 or complete our online contact form for more information or a free consultation.
Jonathan Ashton, Partner and Personal Injury Attorney, began his law career at GT&B in 2007 as a law clerk. He was hired as an associate immediately after passing the Ohio Bar in 2008. Jonathan practices in Personal Injury, representing clients who have been injured and need justice and compensation for them to move forward in their lives.
